I also found this in Granny's list:

Endocannabinoids and the gastrointestinal tract: what are the key questions?
Category: PHYSICAL: DIGESTIVE STSTEM: BOWEL DISORDERS

Bottom line- Cannabinoid (CB1) receptor activation acts neuronally, reducing GI motility, diarrhoea, pain, transient lower oesophageal sphincter relaxations (TLESRs) and emesis, and promoting eating."

- Read more
British Journal of Pharmacology

Does that part I highlighted in red mean that in this study the CB1 activation reduces GERD? And does anybody have a study discussing whether that activation differs from an endocannibinoid versus THC in terms of TLESR prevention?
TheSmokingMonkey Reviewed by TheSmokingMonkey on . GERD - OMG this sucks! Please advise. Hi everyone, Okay. So. I have bursitis that I was taking a lot of Aleve for... and I developed an ulcer/hyperacidic stomach from it. For that, my doctor put me on Prilosec. I took the Prilosec for about a week and then when I stopped taking it I developed GERD (self diagnosis; I understand it's a common rebound effect of the Prilosec?). During this time I was also taking Tramadol as needed for the bursitis, and I was also prescribed Celebrex, which made me bleed (bloody stools), "perhaps Rating: 5